The Ups and Downs of Medication Adherence During COVID-19

"The Ups and Downs of Medication Adherence During COVID-19" was published in PM360 featuring Roshawn Blunt, managing director of 1798, a Fingerpaint company. The article explores the ways COVID-19 has forced pharmacies to keep up with high demand, while consumers recently out of work are scrambling to pay for their refills and copayments.

Blunt explains that the pharma industry can assist consumers during this crisis by providing “new compliance programs through insurance policies,” finding “ways to reduce copayments/coinsurance,” and helping to “assess whether patients qualify for free drug programs.”

It is critically important that patients and consumers are informed of the resources available to them, especially in the midst of COVID-19.